AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
May 20, 2015
30016_dirs_2015-05-20_5b0a735d-8355-4e83-a64f-749bcae9479c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-05-18
Reporting Person: END WILLIAM T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-18 | Common Stock | S | 3527 | $134.5074 | Disposed | 26827 | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $134.50 to $134.52, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26